BillionToOne Inc/$BLLN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About BillionToOne Inc
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
Ticker
$BLLN
Sector
Primary listing
Employees
620
Headquarters
Website
BillionToOne Inc Metrics
BasicAdvanced
$4.1B
-
-$1.07
-
-
Price and volume
Market cap
$4.1B
52-week high
$98.26
52-week low
$84.49
Financial strength
Current ratio
6.172
Quick ratio
5.634
Long term debt to equity
56.845
Total debt to equity
59.976
Interest coverage (TTM)
-43.17%
Profitability
EBITDA (TTM)
1.201
Gross margin (TTM)
65.15%
Net profit margin (TTM)
-4.36%
Operating margin (TTM)
-2.36%
Effective tax rate (TTM)
-0.09%
Revenue per employee (TTM)
$410,000
Management effectiveness
Valuation
Price to revenue (TTM)
3.644
Price to book
-4.19
Price to tangible book (TTM)
-3.91
Price to free cash flow (TTM)
-229.342
Free cash flow yield (TTM)
-0.44%
Free cash flow per share (TTM)
-0.391
Growth
What the Analysts think about BillionToOne Inc
Analyst ratings (Buy, Hold, Sell) for BillionToOne Inc stock.
BillionToOne Inc Financial Performance
Revenues and expenses
BillionToOne Inc Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BillionToOne Inc stock?
BillionToOne Inc (BLLN) has a market cap of $4.1B as of February 13, 2026.
What is the P/E ratio for BillionToOne Inc stock?
The price to earnings (P/E) ratio for BillionToOne Inc (BLLN) stock is 0 as of February 13, 2026.
Does BillionToOne Inc stock pay dividends?
No, BillionToOne Inc (BLLN) stock does not pay dividends to its shareholders as of February 13, 2026.
When is the next BillionToOne Inc dividend payment date?
BillionToOne Inc (BLLN) stock does not pay dividends to its shareholders.
What is the beta indicator for BillionToOne Inc?
BillionToOne Inc (BLLN) does not currently have a Beta indicator.